CCR8 and neoplasm: MAb1 detects the native conformation of human CCR8, as verified by its ability to bind to a subset of Treg cells present within human peripheral blood mononuclear cells (PBMCs) or dissociated tumor cells (DTCs) to a similar extent as a commercially available antibody (Supplementary Figs. 1, 2a).